Detalles de la búsqueda
1.
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
BJU Int
; 132(2): 188-195, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36855895
2.
Investigating Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer.
J Pers Med
; 14(2)2024 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38392564
3.
Relationship between Proclarix and the Aggressiveness of Prostate Cancer.
Mol Diagn Ther
; 27(4): 487-498, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37081322
4.
Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer.
Eur Urol Open Sci
; 53: 46-54, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37441350
5.
Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic Review.
Mol Diagn Ther
; 26(3): 273-281, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35471698
6.
Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review.
Cancers (Basel)
; 14(19)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230670
7.
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand.
Cancers (Basel)
; 14(20)2022 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291883
8.
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?
Int J Biol Markers
; 37(2): 218-223, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35200058
9.
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.
Eur Urol Open Sci
; 37: 38-44, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243388
10.
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.
World J Mens Health
; 40(2): 270-279, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021312
11.
Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI.
Cancers (Basel)
; 14(11)2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681685
12.
Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study.
Infect Dis Ther
; 10(3): 1253-1266, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914265
13.
Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate-specific antigen, digital rectal examination and the prostate-specific antigen density based on digital rectal prostate volume category.
BJUI Compass
; 4(3): 266-268, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37025471
14.
Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study.
Infect Dis Ther
; 11(2): 933, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35171469
Resultados
1 -
14
de 14
1
Próxima >
>>